Meeting
2018 Genitourinary Cancers Symposium
Validation of a genomic classifier to predict adverse pathology in men diagnosed with low risk prostate cancer.
Authors
Hyung Lae Kim
Cedars-Sinai Medical Center, Los Angeles, CA
Hyung Lae Kim , Ping Li , Huei-Chung Huang , Samineh Deheshi , Beatrice Knudsen , Hatem Abou-Ouf , Lucia L.C. Lam , Jennifer Margrave , Marguerite Du Plessis , Elai Davicioni , Jeffrey J. Tosoian , Ashley Ross , John W. Davis , M. Eric Hyndman , Eric A. Klein , Tarek A. Bismar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 71)
DOI
10.1200/JCO.2018.36.6_suppl.71
Abstract #
71
Poster Bd #
D13
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.
First Author: Zachary Kornberg
Poster
2019 Genitourinary Cancers Symposium
Cribriform pattern, Genomic Prostate Score, and adverse pathology at radical prostatectomy in a cohort of prostate cancer patients initially on active surveillance.
First Author: Kyle Brian Zuniga
Poster
2016 Genitourinary Cancers Symposium
Change in a 17-gene genomic prostate score over time in men with low- and intermediate-risk prostate cancer managed with active surveillance.
First Author: Michael S. Leapman
Poster
2023 ASCO Breakthrough
Diagnostic performance of a novel radiomic model for predicting post-treatment prostate cancer recurrence: A comparison to CAPRA and MSKCC nomograms.
First Author: Linda My Huynh